Dimension Inx Corp.
Bioinspired cell delivery system (BioNidum™) that combines 3D-printing, materials science, and digital manufacturing to create implantable cell therapies for organ regeneration
- Sector
- Biotech
- Headquarters
- CHICAGO, IL
- Founded
- 2020
- Latest Form D
- $12M, Feb 2023
- Total capital
- $17.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $17.7M
- 3 Form D · last Feb 2023
- 45 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 6 pending · first 2024
- Rank in peer group#3 of 32
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$12M
- Private capital raisedForm D · SEC · 2nd filing$2.3M
- Private capital raisedForm D · SEC · 1st filing$3.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 32 peers
Line = medianBiotech · Device
- Granted patents#3 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Adam JakusResearcherExecutive Officer, DirectorLinked by 3 patents
- Caralynn CollensExecutive Officer, DirectorNamed in SEC Form D filings
- Ramille ShahExecutive Officer, DirectorNamed in SEC Form D filings
- Rima ChakrabartiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 9- GrantedMethod For Fabrication Of Additively Manufactured, Self-gelling Structures And Their UseUSPTOUS 12,649,018
- GrantedBiointegrative Implantable Cell Encapsulation Device And SystemUSPTOUS 12,139,696
- GrantedMethod For Fabrication Of Additively Manufactured, Self-gelling Structures And Their UseUSPTOUS 11,944,726
Show all 9 patent records
- Method For Fabrication Of Additively Manufactured, Self-gelling Structures And Their UseJun 9, 2026 · US 12,649,018Granted
- Biointegrative Implantable Cell Encapsulation Device And SystemNov 12, 2024 · US 12,139,696Granted
- Method For Fabrication Of Additively Manufactured, Self-gelling Structures And Their UseApr 2, 2024 · US 11,944,726Granted
- Biointegrative Implantable Cell Encapsulation Device And SystemApplication PCTUS2023030458Pending
- Biointegrative Implantable Cell Encapsulation Device And SystemApplication 63399449Pending
- Coated Particles For Solvent-based InksApplication PCTUS2025052388Pending
- Method For Fabrication Of Additively Manufactured, Self-gelling Structures And Their UseApplication PCTUS2022021007Pending
- Coated Particles For Solvent-based InksApplication 63904246Pending
- Milled And Coated Agglomerating Particles For Solvent-based InksApplication 63712053Pending
Related companies, and why
- Vascugen, Inc.Similar federal contract value in Biotech · null in contracts
- Araceli Biosciences Inc.Similar federal contract value in Biotech · null in contracts
- Enable MedicineSimilar federal contract value in Biotech · null in contracts
- Scienture Inc.Similar federal contract value in Biotech · null in contracts
- LABGENIUS LtdSimilar federal contract value in Biotech · null in contracts
- OmniAb, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .